{"DataElement":{"publicId":"6306968","version":"1","preferredName":"Inotuzumab Ozogamicin Per Cycle Combination Dose Administered 1 Decimal Place Milligram per Square Meter Value","preferredDefinition":"The 1 decimal place milligram per square meter numeric combined dose per cycle value measured, assigned or computed related to the inotuzumab ozogamicin administered.","longName":"6306960v1.0:6306967v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6306960","version":"1","preferredName":"Inotuzumab Ozogamicin Per Cycle Combination Dose Administered","preferredDefinition":"A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora._For each, generally denoting a ratio._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence._A collection of things that have been assembled together to form a new whole._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The act of having given something (e.g., a medication or test).","longName":"6324340v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6324340","version":"1","preferredName":"Inotuzumab Ozogamicin Per Cycle Combination Dose","preferredDefinition":"A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.:For each, generally denoting a ratio.:An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.:A collection of things that have been assembled together to form a new whole.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"6324340v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inotuzumab Ozogamicin","conceptCode":"C71542","definition":"A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cycle","conceptCode":"C25472","definition":"An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Combination","conceptCode":"C61517","definition":"A collection of things that have been assembled together to form a new whole.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DD49B54-D540-6008-E053-F662850A8B57","latestVersionIndicator":"Yes","beginDate":"2018-06-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-06-04","modifiedBy":"ONEDATA","dateModified":"2018-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6B8366-07A9-5B9A-E053-F662850ABB56","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-30","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6306967","version":"1","preferredName":"1 Decimal Place Milligram per Square Meter Value","preferredDefinition":"A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit._A numerical quantity measured or assigned or computed.","longName":"6306967v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mg/m2","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6306966","version":"1","preferredName":"Integer::1 Decimal Place Milligram per Square Meter Value","preferredDefinition":"A number with no fractional part, including the negative and positive numbers as well as zero.::1:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.:A numerical quantity measured or assigned or computed.","longName":"C45255::1:C42646:C67402:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Milligram per Square Meter","conceptCode":"C67402","definition":"A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6BA8BB-3460-5B86-E053-F662850A945D","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-30","modifiedBy":"ONEDATA","dateModified":"2018-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6BA8BB-3471-5B86-E053-F662850A945D","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-30","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"INOT_CYC_ino_com_ds_pr_cy_val","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the inotuzumab ozoga","type":"Preferred Question Text","description":"What was the inotuzumab ozogamicin administered combined dose per cycle value?","url":null,"context":"NHLBI"},{"name":"Dose:","type":"Alternate Question Text","description":"Dose:","url":null,"context":"NHLBI"},{"name":"Dose:","type":"Application Standard Question Text","description":"Dose:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6E722D-37DE-7EED-E053-F662850A11D1","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-30","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}